Literature DB >> 21270227

Salmonella enterica serotype Gambia with CTX-M-3 and armA resistance markers: nosocomial infections with a fatal outcome.

D Moissenet1, F-X Weill, G Arlet, D Harrois, J P Girardet, H Vu-Thien.   

Abstract

We report two cases of bacteremia caused by the Salmonella enterica serotype Gambia in our children's hospital, with one fatal outcome. The isolates showed indistinguishable genotypes and infrequent resistance markers: CTX-M-3 extended-spectrum β-lactamase and armA methyltransferase. This is the first report of S. Gambia exhibiting CTX-M-3 and armA markers involved in serious infections.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21270227      PMCID： PMC3122823          DOI： 10.1128/JCM.02127-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  24 in total

1.  Practice guidelines for the management of infectious diarrhea.

Authors:  R L Guerrant; T Van Gilder; T S Steiner; N M Thielman; L Slutsker; R V Tauxe; T Hennessy; P M Griffin; H DuPont; R B Sack; P Tarr; M Neill; I Nachamkin; L B Reller; M T Osterholm; M L Bennish; L K Pickering
Journal:  Clin Infect Dis       Date:  2001-01-30       Impact factor: 9.079

2.  [Typing of extended-spectrum beta-lactamase-producing Salmonella typhimurium strains isolated in a pediatric unit].

Authors:  R A Mhand; A Soukri; H Amarouch; N E Mdaghri; M Benbachir
Journal:  Sante       Date:  1999 Nov-Dec

3.  Nomenclature of plasmid-mediated 16S rRNA methylases responsible for panaminoglycoside resistance.

Authors:  Yohei Doi; Jun-ichi Wachino; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

4.  Non-typhi Salmonella bacteremia in children.

Authors:  E Zaidi; R Bachur; M Harper
Journal:  Pediatr Infect Dis J       Date:  1999-12       Impact factor: 2.129

5.  Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 beta-lactamase production.

Authors:  L Armand-Lefèvre; V Leflon-Guibout; J Bredin; F Barguellil; A Amor; J M Pagès; M-H Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

6.  Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.

Authors:  Jun-ichi Wachino; Keigo Shibayama; Hiroshi Kurokawa; Kouji Kimura; Kunikazu Yamane; Satowa Suzuki; Naohiro Shibata; Yasuyoshi Ike; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

7.  DNA fingerprinting of Ralstonia paucula by infrequent-restriction-site PCR and randomly amplified polymorphic DNA analysis.

Authors:  Didier Moissenet; Hoang Vu-Thien; Yahia Benzerara; Guillaume Arlet
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation.

Authors:  Marc Galimand; Patrice Courvalin; Thierry Lambert
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

9.  Infection due to extended-spectrum beta-lactamase-producing Salmonella enterica subsp. enterica serotype infantis in a neonatal unit.

Authors:  Carmem Lúcia Pessoa-Silva; Cristiana M Toscano; Beatriz Meurer Moreira; Ana Lúcia Santos; Ana Cristina Cisne Frota; Claude Andre Solari; Efigênia L t Amorim; Maria Da Gloria S Carvalho; Lúcia Martins Teixeira; William R Jarvis
Journal:  J Pediatr       Date:  2002-09       Impact factor: 4.406

10.  [Ciprofloxacin after clinical failure of beta-lactam antibiotics in children with salmonellosis].

Authors:  F Moulin; H Sauvé-Martin; E Marc; Mathie M Lorrot; M Soulier; S Ravilly; J Raymond; D Gendrel
Journal:  Arch Pediatr       Date:  2003-07       Impact factor: 1.180
View more
  1 in total

1.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.